An observational study in Pain, Acute and Liver Diseases, sponsored by Kocaeli University. Status unknown at 1 site in Turkey. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-02-16.
Sponsored by Kocaeli University · Observational
Liver biopsy is still used as the gold standard in the diagnosis of many liver diseases. During the observation after liver biopsy, patients are hospitalized on their right side, which is the biopsy side, with the thought that adverse events (complications) such as bleeding or bile leakage will be less. Patients who do not develop complications after 4-6 hours of observation are discharged home. Some of the patients state that the right side-lying position for 4-6 hours is uncomfortable than the biopsy itself, and they prefer to lie on their back. In our study, researchers aim to investigate the rate of complications after biopsy, what recovery position found more acceptable by the patients.
Liver biopsy is still used as the gold standard in the diagnosis of many liver diseases. The health practice notification (SUT) makes the diagnosis with liver biopsy mandatory for the treatment of chronic viral hepatitis (Chronic Hepatitis B Inf. And Chronic Hepatitis C Inf.). In daily gastroenterology practice, clinicians frequently perform a liver biopsy for the diagnosis of non-alcoholic fatty liver (NASH), and to a lesser extent, for the diagnosis of Wilson Disease and Hemochromatosis.
During the observation after liver biopsy, patients are hospitalized on their right side, which is the biopsy side, with the argument that there will be less bleeding or bile leakage complications. Patients who do not develop complications after 4-6 hours of observation are discharged to their homes. (1) In this study, researchers aimed to investigate the post-biopsy position of patients who were referred to the clinic for liver biopsy, the rate of complications after biopsy, and to what extent the patients found the procedure acceptable according to their post-biopsy position.
2,083 studies on the registry are indexed under Liver Diseases; 392 are open to participants now.
This study's planned enrollment of 100 is below the median of 167 across 683 observational studies indexed under Liver Diseases.
Browse Liver Diseases studies →Kocaeli University is the lead sponsor of 210 studies on the registry; 38 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Acute and chronic liver damaged patients
Exclusion Criteria:
1.Refuse to give written informed consent
Liver biopsy is a procedure to obtain small amount of liver by a needle.
Pain scores
Patient reported pain scores will be assesed by visual analog scale, minimum score "0" refers no pain and "10" refers worst pain
Time frame: Immediately after the procedure
Complications
Complications such as liver lickage ,bleeding, infection at biopsy site will be recorded
Time frame: within 2 weeks after the procedure
Plan to share: Yes — Anonymised pain scores and descriptive data
Supporting information: Csr, Analytic code
This study is status unknown, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kocaeli University